Total Payments
$511.99
2023 Payments
$45.90
Companies
10
Transactions
31
Medicare Patients
807
Medicare Billing
$35,544
Payment Breakdown by Category
Food & Beverage$511.99 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $511.99 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $147.54 | 9 | $0 (2023) |
| Lilly USA, LLC | $96.67 | 5 | $0 (2022) |
| ABBVIE INC. | $96.02 | 6 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $47.54 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $47.18 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $17.80 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $16.82 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.89 | 1 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $14.60 | 1 | $0 (2022) |
| PFIZER INC. | $12.93 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $45.90 | 3 | Novo Nordisk Inc ($32.12) |
| 2022 | $253.76 | 16 | ABBVIE INC. ($61.33) |
| 2021 | $212.33 | 12 | Novo Nordisk Inc ($83.66) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 03/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Obesity | ||||||
| 12/12/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: PRIMARY CARE | ||||||
| 10/12/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: PRIMARY CARE | ||||||
| 10/11/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Diabetes | ||||||
| 09/22/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.92 | General |
| 08/16/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Diabetes | ||||||
| 07/20/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/05/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2022 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Diabetes | ||||||
| 03/29/2022 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Diabetes | ||||||
| 03/23/2022 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: AED | ||||||
| 03/08/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: PRIMARY CARE | ||||||
| 02/24/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Obesity | ||||||
| 02/16/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.34 | General |
| 01/07/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Diabetes | ||||||
| 08/12/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Obesity | ||||||
| 08/04/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Diabetes | ||||||
| 06/03/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Obesity | ||||||
| 04/22/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 133 | 170 | $10,093 | $3,516 |
| 2022 | 7 | 184 | 239 | $20,726 | $11,212 |
| 2021 | 8 | 239 | 275 | $21,064 | $12,185 |
| 2020 | 8 | 251 | 319 | $22,919 | $8,631 |
Total Patients
807
Total Services
1,003
Medicare Billing
$35,544
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 36 | 36 | $3,168 | $1,246 | 39.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 36 | 71 | $2,911 | $1,152 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 15 | $2,599 | $592.43 | 22.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 30 | 30 | $1,230 | $486.00 | 39.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 18 | $185.00 | $39.60 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 75 | $9,375 | $4,628 | 49.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $3,640 | $2,910 | 79.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 53 | $4,982 | $2,276 | 45.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 15 | 19 | $1,615 | $964.60 | 59.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 20 | 25 | $625.00 | $331.41 | 53.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 22 | 24 | $264.00 | $71.10 | 26.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 12 | 15 | $225.00 | $31.01 | 13.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 60 | $7,500 | $4,330 | 57.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 28 | 28 | $3,640 | $2,968 | 81.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 53 | $4,982 | $2,371 | 47.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 30 | 30 | $2,550 | $1,488 | 58.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 42 | 48 | $1,200 | $629.33 | 52.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $600.00 | $312.40 | 52.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 20 | 22 | $242.00 | $66.00 | 27.3% |
| 96161 | Administration and interpretation of caregiver-focused health risk assessment | Office | 2021 | 12 | 14 | $350.00 | $19.92 | 5.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 80 | 124 | $11,656 | $3,910 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $2,730 | $1,936 | 70.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 48 | $6,000 | $1,826 | 30.4% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 15 | 15 | $450.00 | $415.50 | 92.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 16 | $480.00 | $249.92 | 52.1% |
About Stephanie Woosley, APRN
Stephanie Woosley, APRN is a Family healthcare provider based in Brandenburg, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2018. The National Provider Identifier (NPI) number assigned to this provider is 1760973895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Woosley, APRN has received a total of $511.99 in payments from pharmaceutical and medical device companies, with $45.90 received in 2023. These payments were reported across 31 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($511.99).
As a Medicare-enrolled provider, Woosley has provided services to 807 Medicare beneficiaries, totaling 1,003 services with total Medicare billing of $35,544. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Brandenburg, KY
- Active Since 05/24/2018
- Last Updated 05/24/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1760973895
Products in Payments
- UBRELVY (Drug) $55.21
- Ozempic (Drug) $51.17
- NURTEC ODT (Drug) $47.54
- Saxenda (Drug) $47.14
- QULIPTA (Drug) $40.81
- TRULICITY (Drug) $37.44
- BASAGLAR (Drug) $34.99
- Wegovy (Drug) $34.25
- EMGALITY (Drug) $24.24
- FARXIGA (Drug) $18.92
- ANORO ELLIPTA (Drug) $17.80
- ENTRESTO (Drug) $16.82
- Rybelsus (Drug) $14.98
- XIFAXAN (Drug) $14.89
- TROKENDI XR (Drug) $14.60
- ELIQUIS (Drug) $12.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Brandenburg
Mrs. Mallory Lynch, Aprn, APRN
Family — Payments: $3,112
Family $3,112
Mrs. Celeste Farmer, Aprn, APRN
Family — Payments: $2,311
Family $2,311
Mr. Christopher Pickering, Np, NP
Family — Payments: $540.00
Family $540.00
Christine Myers, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $317.62
Family $317.62
Marquita Brown, Aprn, APRN
Family — Payments: $256.31
Family $256.31
Mrs. Holly Schultz Pollock, Aprn, APRN
Family — Payments: $69.81
Family $69.81